Table 3.

Prevalence of predictive biomarkers among patients with Claudin 18.2-positive GC.

Biomarker	Kubota et al. [56] N = 98 (%)	Pellino et al. [54] N = 117 (%)
HER2	15 (15.3)	17 (14.5)
MSI-H/dMMR	5 (5.1)	15 (12.8)
PD-L1 CPS ≥ 5	39 (41.9)	21 (17.9)